Pasouk

Pasouk is a leading biotechnology research company dedicated to producing high-quality vaccines and biological products for veterinary medicine. Established in 1994, Pasouk prioritizes innovation and strives to meet the country's needs while achieving self-sufficiency in the production of critical veterinary products.

With over 20 years of experience, Pasouk specializes in the production and supply of poultry vaccines, including well-known products like Newpasol 101, Newpasol 102, Newpasol 103, Flupasol, and Gampasol. These vaccines play a crucial role in preventing and controlling significant poultry diseases such as Newcastle, influenza, and Gumboro. Furthermore, Pasouk has successfully developed strategic vaccines for foot and mouth disease (FMD), the highly pathogenic avian influenza strain (H5N8), Newpasol 100 (NDV Strain GVII), and Pestivax for sheep and goat plague (PPR). Pasouk also produces HI Antigens for diagnostic tests of influenza and Newcastle disease. The primary address is Akbari St., 22 Bahman St., Ashrafi Esfahani Hwy Unit 1, No 1, tehran, 1473194344, IR.

Pasouk's commitment to quality is evident in its use of high-grade raw materials, such as SPF embryonated eggs and the company's own superior oil adjuvant. All biological products are manufactured in compliance with the highest international standards and GMP principles, ensuring accurate quality control and approval from the Iran Veterinary Organization. Pasouk's R&D department is actively involved in extensive studies on other strategic products across diverse fields, as well as the research and production of additional vaccines and biological products for the livestock and poultry industry. We invite Pasouk's management team to create a customized and exclusive company showcase and product listing on our platform to further enhance its market presence.